Eric McDade, DO
Enriched profileProfessor of Neurology, Washington University School of Medicine; Associate Director, DIAN Clinical Core and DIAN Trials Unit · Washington University in St. Louis School of Medicine
Eric McDade is Professor of Neurology, Washington University School of Medicine; Associate Director, DIAN Clinical Core and DIAN Trials Unit at Washington University in St. Louis School of Medicine. OpenAlex indexes 450 publications with 22,402 citations (h-index 65); ClinicalTrials.gov lists 3 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Neurology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Eric McDade, DO, is Professor of Neurology, Washington University School of Medicine at Washington University in St. Louis School of Medicine. The public record shows 450 publications with 22,402 citations (h-index 65), centered on Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Functional Brain Connectivity Studies. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 9 companies, 5 NIH-funded awards (2016–2026).
- Most recent indexed publication: 2026 · Neurology
- Top research focus: Dementia and Cognitive Impairment Research
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 9 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 28 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 165.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Sponsor: Washington University School of Medicine
- A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Sponsor: Washington University School of Medicine
- Dominantly Inherited Alzheimer Network (DIAN)
Sponsor: Washington University School of Medicine
Industry payments
Updated 27 Aug 2026
9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Alnylam Pharmaceuticals Inc.Program year20257 payments
- Janssen Global Services, LLCProgram year202510 payments
- SANOFI US SERVICES INC.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Cholinesterase Inhibitor43.6%Donepezil Hcl75%Rivastigmine25%Part D<11 patientsN-methyl-D-aspartate Receptor Antagonist24.5%Memantine Hcl100%Part D≥16 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
5 NIH research awards on record, funded 2016–2026 per NIH RePORTER. The latest:
- Multidisciplinary Training in Alzheimer and Related Dementias
Washington University
FY2026$430,809T32AG058518
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- GWAS meta-analysis of cerebrospinal fluid Alzheimer's biomarkers reveals loci regulating lipids, brain volume and autophagy.
Nature communications
Meta-analysis2026 - Target product profiles for treatments to delay or prevent symptomatic Alzheimer's disease.
Nature medicine
Review2026 - Predicting onset of symptomatic Alzheimer's disease with plasma p-tau217 clocks.
Nature medicine
Article2026
Most-cited works
by citation count (OpenAlex)- 01Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's DiseaseArticle3,859 citations2012
- 02Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association WorkgroupArticle2,389 citations2024
- 03
- 04Normative spatiotemporal gait parameters in older adultsArticle813 citations2011
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/eric-mcdade-do
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/eric-mcdade-64a71b3
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - LinkedIn
linkedin.com/in/eric-mcdade-cogneuro
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- Other
dian.wustl.edu/items/2025-family-conference-welcome-remarks-part-1
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dian.wustl.edu ↗ - Other
ir.alzamend.com/news-events/press-releases/detail/13/alzamend-neuro-announces-appointment-of-dr-eric-mcdade
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ir.alzamend.com ↗ - LinkedIn
LinkedIn profile: Eric McDade - Washington University School of Medicine in St. Louis
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- DO (Doctor of Osteopathic Medicine)
Chicago College of Osteopathic Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ir.alzamend.com ↗ - BA in Psychology
Canisius College
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ir.alzamend.com ↗ - Board certified in Neurology
American Board of Psychiatry and Neurology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ir.alzamend.com ↗ - Certification in Behavioral Neurology
United Council for Neurologic Subspecialties
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ir.alzamend.com ↗
Editorial & leadership roles
journal and society appointments- Associate Director
DIAN Clinical Core
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dian.wustl.edu ↗ - Associate Director
DIAN Trials Unit (DIAN-TU)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dian.wustl.edu ↗ - Principal Investigator
DIAN Expanded Registry
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dian.wustl.edu ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physicians.wustl.edu ↗
- Scientific Advisory Board member
Alzamend Neuro, Inc.
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ir.alzamend.com ↗ - Scientific Advisor
Cumulus Neuroscience
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →theorg.com ↗
Media & interviews
press, podcasts and appearances- NeurologyLive video interview/commentary series on Alzheimer's disease management
e.g. "Considerations for Management of Alzheimer's Disease"
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →neurologylive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research